Clinical Trials

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06250829 2024-02-09

Pre-PLaN

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Phase 1 Unknown

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06228508 2024-01-29

BiliBro

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06207292 2024-01-16

STARTNEWERA-OM

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05296278 2024-01-10

Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05248022 2024-01-09

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

98 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06195683 2024-01-08

NSCLC

23 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04789252 2024-01-02

TUM-DC

64 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms

NCT04937972 2023-12-29

FLYFLY

71 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05611879 2023-12-29

Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02098954 2023-12-27

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03646994 2023-12-27

Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03647111 2023-12-27

Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03647592 2023-12-27

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04322591 2023-12-27

POSEIDON

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04397432 2023-12-27

SELECT-1

878 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04401059 2023-12-27

SELECT-2

Phase 4 Unknown

744 enrolled

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06182800 2023-12-27

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06180239 2023-12-22

Segmentectomy vs Lobectomy

800 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02950337 2023-12-21

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

41 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06163846 2023-12-20

Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.

415 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05542485 2023-12-15

PLAN

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05730972 2023-12-13

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

188 enrolled

Cancer Pain, Carcinoma, Non-Small-Cell Lung

NCT06165874 2023-12-12

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04636775 2023-12-11

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

46 enrolled

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02871856 2023-12-05

ILST

2,000 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05291403 2023-11-18

Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion

141 enrolled

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT05812534 2023-11-18

CBC